We are partner organization in the EUROoC!
We are partner organization in the European interdisciplinary training network for organ-on-chip technology (EUROoC)
What does it mean to work with organ-on-chip? What is 3R? Where are the opportunities and benefits for understanding human cellular mechanisms, modeling human diseases, and screening drugs?
The field of organ-on-chip (OoC) rapidly moved forward due to its promising impact on drug development and personalized disease treatment. Because of this, EUROoC, the first European training program on OoC, was founded. Participants from different disciplines, such as biology, engineering, medicine, physics and chemistry come together. The common aim: the reduction of animal experiments. The University Hospital Jena is represented by the doctoral student Aina Kehinde Oluwasegun and our biotech chips.
EUROoC invites you to a virtual lab tour in the clip “Organ-on-Chip and the 3R: A virtual lab tour”. Here you will get insights into the Europe-wide OoC research.
Our biochips are presented in minutes three and five.
More news from Dynamic42:
Blog
Compound adsorption by soft polymer biochips and the consequences on preclinical research
In this article, we will discuss common issues observed when working with biochips made of PDMS, most commonly used alternatives, and desired properties for biochip materials. But most importantly, we will present alternative biochips showing low adsorptions rates but also unique biocompatibility for high grade drug screening.
Read MoreBlog
Introduction to drug discovery and drug development
In this blog we will provide you with an introduction to the drug development process from target validation to post-market surveillance to give you a better understanding on how new drugs are being developed.
Read MoreBlog
The faces of Dynamic42: Georg Machnik
As an expert in business development, Georg enriches our team at Dynamic42. With his creative approach and many years of experience in medical technology and project management, Georg is a valuable addition to our team.
Read More